Log In
Register
Facebook icon
Instagram icon
Twitter X icon
LinkedIn icon
Business
Research
Treatments
News
Products
Multimedia
Site Map
2018
December
06
Revance Releases Phase 3 Study Results for Toxin RT002
2019 NRS Rosacea Research Grants Available
Merz Launches new XEOMIN “Later Haters” Campaign
Page 1 of 1